Evidence map›Paper›PMID 33406813›Full record

ArticleHaematologica2022

Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance.

Martina Moras, Claude Hattab, Pedro Gonzalez-Menendez, Claudio M Fader, Michael Dussiot, Jerome Larghero, Caroline Le Van Kim, Sandrina Kinet, Naomi Taylor, Sophie D Lefevre and 1 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Martina MorasUniversité de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
Claude HattabUniversité de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
Pedro Gonzalez-MenendezLaboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier.
Claudio M FaderLaboratorio de Biología Celular y Molecular, Instituto de Histología y Embriología (IHEM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina; Facultad de Odontología, Universidad Nacional de Cuyo, Mendoza.
Michael DussiotLaboratoire d'Excellence GR-Ex, F-75015, Paris, France; Université de Paris, UMR_S1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implication, Inserm, F-75014 Paris.
Jerome LargheroAP-HP, Hôpital Saint-Louis, Unité de Thérapie cellulaire, Paris.
Caroline Le Van KimUniversité de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris.
Sandrina KinetLaboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier.
Naomi TaylorLaboratoire d'Excellence GR-Ex, F-75015, Paris, France; Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France; Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
Sophie D LefevreUniversité de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris. sophie.lefevre@inserm.fr.
Mariano A OstuniUniversité de Paris, UMR_S1134, BIGR, Inserm, F-75015 Paris, France; Institut National de Transfusion Sanguine, F-75015 Paris, France; Laboratoire d'Excellence GR-Ex, F-75015, Paris. mariano.ostuni@inserm.fr.
Université Paris Cité · FRUniversité de Montpellier · FRCentre National de la Recherche Scientifique · FRHôpital Saint-Louis · FRInserm · FRUniversidad Nacional de Cuyo · AR

Funding

Reprogramming hematopoietic stem cell (HSC) differentiation via metabolic conditZIABC011924 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TAYLOR, NAOMI · 2019 to 2025
$9.0M
6 · The paper itself

Abstract

Erythroblast maturation in mammals is dependent on organelle clearance throughout terminal erythropoiesis. We studied the role of the outer mitochondrial membrane protein voltage-dependent anion channel-1 (VDAC1) in human terminal erythropoiesis. We show that short hairpin (shRNA)-mediated downregulation of VDAC1 accelerates erythroblast maturation. Thereafter, erythroblasts are blocked at the orthochromatic stage, exhibiting a significant decreased level of enucleation, concomitant with an increased cell death. We demonstrate that mitochondria clearance starts at the transition from basophilic to polychromatic erythroblast, and that VDAC1 downregulation induces the mitochondrial retention. In damaged mitochondria from non-erythroid cells, VDAC1 was identified as a target for Parkin-mediated ubiquitination to recruit the phagophore. Here, we showed that VDAC1 is involved in phagophore's membrane recruitment regulating selective mitophagy of still functional mitochondria from human erythroblasts. These findings demonstrate for the first time a crucial role for VDAC1 in human erythroblast terminal differentiation, regulating mitochondria clearance.

Indexed as

MitochondriaMitophagyAnimalsApoptosisCell DifferentiationErythroblastsErythropoiesisHumansMammalsVoltage-Dependent Anion Channel 1VDAC1 protein, humanVoltage-Dependent Anion Channel 1

Identifiers

PMID33406813
PMCPMC8719069
OpenAlexW3118391609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.